DrachmanDB. Myasthenia gravis. N Engl J Med, 1994; 330(25):1797–1810.
2.
PhillipsLH. The epidemiology of myasthenia gravis. Semin Neurol, 2004; 24(1):17–20.
3.
PhillipsLH2nd. The epidemiology of myasthenia gravis. Ann NY Acad Sci, 2003; 998:407–412.
4.
PhillipsLH2nd, TornerJC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology, 1996; 47(5):1233–1238.
5.
IsbisterCM, MackenziePJ, AndersonD, WadeNK, OgerJ. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler, 2003; 9(6):550–553.
6.
OosterhuisHJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry, 1989; 52(10):1121–1127.
7.
BershadEM, FeenES, SuarezJI. Myasthenia gravis crisis. South Med J, 2008; 101(1):63–69.
8.
SellmanMS, MayerRF. Treatment of myasthenic crisis in late life. South Med J, 1985; 78(10):1208–1210.
9.
ThomasCE, MayerSA, GungorY, SwarupR, WebsterEA, ChangI, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology, 1997; 48(5):1253–1260.
10.
VaidyaH. Case of the month: unusual presentation of myasthenia gravis with acute respiratory failure in the emergency room. Emerg Med J, 2006; 23(5):410–413.
11.
KimWH, KimJH, KimEK, YunSP, KimKK, KimWC, JeongHC. Myasthenia gravis presenting as isolated respiratory failure: a case report. Korean J Intern Med, 2010; 25(1):101–104.
12.
EtheridgeSM. Paralytic shellfish poisoning: seafood safety and human health perspectives. Toxicon, 2010; 56(2):108–122.
CavalcanteP, Le PanseR, Berrih-AkninS, MaggiL, AntozziC, BaggiF, et al. The thymus in myasthenia gravis: site of “innate autoimmunity”?. Muscle Nerve, 2011; 44(4):467–484.